Mazumder Upal Kanti, Gupta Malaya, Pal Dilipkumar, Bhattacharya Shiladitya
Department of Pharmaceutical Technology, Jadavpur University, Kolkata-700 032, West Bengal, India.
Acta Pol Pharm. 2003 Jul-Aug;60(4):317-23.
Methanol extract of Cuscuta reflexa Roxb. stem (MECR) contain flavonoids (0.2%) and Corchorus olitorius Linn. seed (MECO) was found to contain steroids and cardenolide glycosides. Effects of multiple weekly dose of MECR (25, 50, 75 mg/kg, i.p.) and MECO (15, 20, 25 mg/kg, i.p.) on liver and kidney functions and hematological parameters in mice were studied. No significant alteration of RBC count and hemoglobin content was observed in all dose level of treatment in MECR and MECO treated mice whereas significant increase of clotting time was seen in moderate and high doses in both case. MECR and MECO both caused significant increase in WBC count only in high dose level of treatment. Both the extracts in medium and high dose level increased SGOT, SGPT, NPN and plasma cholesterol significantly. Serum alkaline phosphatase and total bilirubin were also increased by both moderate and high dose level of treatments in MECR and MECO treated mice respectively. Low dose of both the extract did not exhibit any significant change of creatinine and serum protein level. But high dose level of MECR and MECO significantly increased creatinine level. Increase in plasma cholesterol may be due to decrease in cholesterol catabolism owing to liver dysfunction of due to the intake of MECO itself as it was found to be steroid in nature. Elevated level of SGOT, SGPT and serum alkaline phosphatase activity in moderate and high dose level of weekly treated mice may be due to improper liver function following the treatment. Increased urea, non protein nitrogen and creatinine content in blood have been observed with impaired renal function. The slightly higher toxicity in case of MECO treated mice may be due to the presence of cardenolide glycosides in the ME of C. olitorius seed. However, low doses of MECR and MECO (25 and 15 mg/kg, i.p. respectively) did not exhibit any remarkable change on liver and kidney functions and hematological parameters.
菟丝子茎甲醇提取物(MECR)含有黄酮类化合物(0.2%),而黄麻籽(MECO)被发现含有甾体和强心苷类化合物。研究了多次每周剂量的MECR(25、50、75毫克/千克,腹腔注射)和MECO(15、20、25毫克/千克,腹腔注射)对小鼠肝脏和肾脏功能以及血液学参数的影响。在MECR和MECO处理的小鼠中,所有剂量水平的处理均未观察到红细胞计数和血红蛋白含量有显著变化,而在两种情况下,中、高剂量均出现凝血时间显著延长。MECR和MECO仅在高剂量水平的处理中导致白细胞计数显著增加。两种提取物的中、高剂量水平均显著增加了血清谷草转氨酶、谷丙转氨酶、非蛋白氮和血浆胆固醇。在MECR和MECO处理的小鼠中,中、高剂量水平的处理分别使血清碱性磷酸酶和总胆红素也增加。两种提取物的低剂量均未使肌酐和血清蛋白水平出现任何显著变化。但MECR和MECO的高剂量水平显著增加了肌酐水平。血浆胆固醇升高可能是由于肝脏功能障碍导致胆固醇分解代谢减少,或者是由于摄入了本身具有甾体性质的MECO。每周中、高剂量处理的小鼠血清谷草转氨酶、谷丙转氨酶和血清碱性磷酸酶活性升高可能是由于处理后肝功能异常。血液中尿素、非蛋白氮和肌酐含量增加表明肾功能受损。MECO处理的小鼠毒性略高可能是由于黄麻籽提取物中存在强心苷类化合物。然而,低剂量的MECR和MECO(分别为25和15毫克/千克,腹腔注射)对肝脏和肾脏功能以及血液学参数未表现出任何显著变化。